👤 Yuki Noguchi

3 articles tracked

About this journalist

Articles
3
2026-09-27 – 2026-11-02
Claims per article
50
150 extracted in total
Hedged claims
11%
corpus average 9%
Typical length
6,922
characters
Writes for NPR.
Hedged claims are ones written with attribution or uncertainty (“reportedly”, “according to”). A higher rate is not a fault: it is often careful sourcing. How these are measured.

What they cover

Health
100%
Most-tagged topics
AmericansCenter for Asian Health Research and EducationFloridaGoldmanJAMA OphthalmologyMarylandMerckModerna

Leaning

None of these articles has a leaning score yet.

More from this journalist

Ordered by how many newsrooms covered the same event.
2026-11-02 · NPR · Health
This woman defied lethal cancer. Can mRNA vaccines make that possible for others?
no other outlet in the corpus covered this
2026-10-10 · NPR · Health
Ongoing lawsuits allege GLP-1s can cause serious harm. But we don't know how often
no other outlet in the corpus covered this
2026-09-27 · NPR · Health
From professor to patient: One man's journey on the frontier of lung cancer treatment
no other outlet in the corpus covered this

What they said would happen

2026-09-27 · NPR
From professor to patient: One man's journey on the frontier of lung cancer treatment
🔮 "Super ironic that I would be co-leading the center that supports research and education in this disease, and I get diagnosed myself," he says. assertive
2026-10-10 · NPR
Ongoing lawsuits allege GLP-1s can cause serious harm. But we don't know how often
🔮 That winter, on New Year's Eve, Engel woke up feeling as if a patch covered his right eye: "I couldn't see anything. assertive
2026-11-03 · NPR
This woman defied lethal cancer. Can mRNA vaccines make that possible for others?
🔮 "I had no symptoms, no side effects — to the point where I was actually worried that maybe it was not helping. assertive
Forward-looking sentences extracted from their articles, oldest first. Nothing here checks whether any of it turned out to be right.
💬Give feedback · no sign-in needed

No sign-in needed for now. Your note is sent without a name, so it cannot be answered.

🕘History 🎫Support
Terms · Privacy · beta v2.0.0
Articles to 4 Nov 2026